Repository logo
 
Loading...
Thumbnail Image
Publication

The Use of Recombinant Activated FVII (rFVIIa, Novoseven®) in the Treatment of Patients with Haemophilia and Inhibitors

Use this identifier to reference this record.
Name:Description:Size:Format: 
Poster FVIIaR Canada 2000.pdf74.97 KBAdobe PDF Download

Advisor(s)

Abstract(s)

Description

Keywords

Factor VIIa Hemofilia A Hemofilia B Estudos Retrospectivos

Citation

IN: XXIV International Congress of the World Federation of Hemophilia, 2000, 16 a 21 Julho. Montreal, Canadá.

Research Projects

Organizational Units

Journal Issue

Publisher

Serviço de Imunohemoterapia do Hospital de S. José e do Hospital de Sta. Maria

CC License